Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant.
Journal: Nature communications
Published: December 10, 2015
Discovery and development of DNA methylation-based biomarkers for lung cancer.
Journal: Epigenomics
Published: March 04, 2014
Integrative analysis of two cell lines derived from a non-small-lung cancer patient--a panomics approach.
Journal: Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
Published: December 04, 2013
Loss of NAPRT1 expression by tumor-specific promoter methylation provides a novel predictive biomarker for NAMPT inhibitors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 08, 2013
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.
Journal: Genome research
Published: October 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026